TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Magnus Nylander Biocare AB
Closing information (x1000 NOK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
53
|
87
|
241 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
-5
|
-324
|
84 |
| EBITDA |
-7
|
-324
|
32 |
| Total assets |
397
|
707
|
756 |
| Current assets |
371
|
682
|
730 |
| Current liabilities |
255
|
569
|
281 |
| Equity capital |
138
|
133
|
471 |
| - share capital |
101
|
95
|
98 |
| Employees (average) |
1
|
1
|
0 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
34.8%
|
18.8%
|
62.3% |
| Turnover per employee |
53
|
87 | |
| Profit as a percentage of turnover |
-9.4%
|
-372.4%
|
34.9% |
| Return on assets (ROA) |
-1.3%
|
-45.8%
|
11.1% |
| Current ratio |
145.5%
|
119.9%
|
259.8% |
| Return on equity (ROE) |
-3.6%
|
-243.6%
|
17.8% |
| Change turnover |
-41
|
-147
|
-65 |
| Change turnover % |
-43%
|
-63%
|
-21% |
| Chg. No. of employees |
0
|
1
|
-1 |
| Chg. No. of employees % | 0% | -100% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.